a1 Adrenergic receptors mediate a variety of physiological responses and have been well studied in the cardiovascular and peripheral nervous system. However, their role in the central nervous system remains ill defined because of the lack of highly specific ligands to the a1 receptor subtypes. Here, we have employed gene targeting to elucidate the role of a1d receptors in vivo. In addition to disrupting function, the insertion of the lacZ gene into the a1d receptor locus enabled the specific identification of cells expressing the a1d gene. These cells are localized in the cortex, hippocampus, olfactory bulb, dorsal geniculate and ventral posterolateral nuclei of the thalamus. Behaviorally, the a1d À/À mice show normal locomotor activity during the subjective day, or resting phase of their cycle. However, during subjective night, or active phase, wheel-running activity is significantly reduced in mutant mice. Furthermore, these mice show a reduction in exploratory rearing behavior in a novel cage environment. Lastly, a1d À/À mice show reduced hyperlocomotion after acute amphetamine administration. Together, these data reveal the functional importance of a1d adrenoceptors in mediating a variety of stimulus-induced changes in locomotor behaviors. While the sensitivity of noradrenergic neurons to environmental stimuli has been well documented, our data demonstrate that at least some of these post-synaptic responses are mediated by a1d adrenergic receptors. Molecular Psychiatry (2003) 8, 664-672. doi:10.1038/sj.mp.4001351Keywords: gene targeting; a1d adrenergic receptor; mouse; amphetamine; cocaine Adrenergic receptors mediate a variety of physiological responses including the regulation of cardiovascular function, glycogenolysis and the contractility of the urinary tract. These receptors are targets for norepinephrine and epinephrine and have been well studied in the peripheral nervous system. However, their role in the central nervous system (CNS) remains enigmatic. The noradrenergic system is important for numerous behavioral states, such as arousal, attention, vigilance and anxiety. 1-4 Furthermore, activation of the noradrenergic system has been implicated in mediating responses induced specifically by changes in stimuli, such as exploratory behavior, arousal and circadian behavior. [5][6][7][8] Noradrenergic activation may also be involved in locomotor and rewarding effects of drugs of abuse, such as psychostimulants and opiates. A variety of studies have documented the existence of interactions between ascending noradrenergic and dopaminergic systems. [9][10][11][12] The mechanisms underlying these interactions appear to involve stimulation of a1 adrenergic receptors. [13][14][15] For example, injection of prazosin, a non-selective a1 antagonist prior to administration of D-amphetamine, reduces locomotor hyperactivity. [16][17][18] and alters the release of extracellular dopamine in the nucleus accumbens. 17 Furthermore, stimulation of a1 receptors can elicit changes in glutamatergic neurons in the prefrontal ...